Liuping Luo

机构：Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital

发表论文 18 篇 · 总被引 222 次 · h-index 6

代表论文

Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion (2021 · Molecular Cancer · 被引 126)
Lenvatinib Plus Camrelizumab versus Lenvatinib Monotherapy as Post-Progression Treatment for Advanced Hepatocellular Carcinoma: A Short-Term Prognostic Study (2021 · Cancer Management and Research · 被引 25)
Radiofrequency ablation versus repeat hepatectomy in the treatment of recurrent hepatocellular carcinoma in subcapsular location: a retrospective cohort study (2021 · World Journal of Surgical Oncology · 被引 20)
<p>Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinoma</p> (2019 · Cancer Management and Research · 被引 15)
Perioperative safety, oncologic outcome, and risk factors of salvage liver resection for initially unresectable hepatocellular carcinoma converted by transarterial chemoembolization plus tyrosine kinase inhibitor and anti-PD-1 antibody: a retrospective multicenter study of 83 patients (2023 · Hepatology International · 被引 13)
High expression levels of CLEC4M indicate poor prognosis in patients with hepatocellular carcinoma (2020 · Oncology Letters · 被引 12)